QR kȏd

In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant Mycobacterium tuberculosis Strains

Current therapy for pulmonary tuberculosis involves 6 months of treatment with isoniazid, pyrazinamide, rifampin, and ethambutol or streptomycin for reliable treatment efficacy. The long treatment period increases the probability of noncompliance, leading to the generation of multidrug-resistant iso...

Cijeli opis

Spremljeno u:
Izdano u:Antimicrob Agents Chemother
Glavni autori: Oleksijew, Andy, Meulbroek, Jon, Ewing, Patty, Jarvis, Ken, Mitten, Mike, Paige, Lenette, Tovcimak, Ann, Nukkula, Mike, Chu, Daniel, Alder, Jeffrey D.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1998
Teme:
Experimental Therapeutics
Online pristup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105917/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9756775/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.10.2674
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti